Zimpfer, C., Figl, R., & Schadendorf, D. (2003). Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: A multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG). Melanoma research, 13(5), .
Chicago Style (17th ed.) CitationZimpfer, Christine, Robert Figl, and Dirk Schadendorf. "Randomized Phase II Study of Weekly Paclitaxel Versus Paclitaxel and Carboplatin as Second-line Therapy in Disseminated Melanoma: A Multicentre Trial of the Dermatologic Co-operative Oncology Group (DeCOG)." Melanoma Research 13, no. 5 (2003).
MLA (9th ed.) CitationZimpfer, Christine, et al. "Randomized Phase II Study of Weekly Paclitaxel Versus Paclitaxel and Carboplatin as Second-line Therapy in Disseminated Melanoma: A Multicentre Trial of the Dermatologic Co-operative Oncology Group (DeCOG)." Melanoma Research, vol. 13, no. 5, 2003.